Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / final9knumclusters / clust_826.txt

Download this file

113 lines (112 with data), 7.1 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
Alanine aminotransferase (ALT) =< 3 x ULN

Serum alanine aminotransferase (ALT) < 2.5 x ULN

Alanine aminotransferase (ALT) =< 3.0 X ULN, within 14 days of registration

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT [SGPT]) ?2.5 × the ULN;

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 2 x ULN OR if hepatic involvement by lymphoma: ALT =< 5 x ULN

Alanine aminotransferase (ALT) < 2 x institutional ULN within 14 days of enrollment to trial

Alanine aminotransferase (ALT) =< 3.0 X ULN

alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Alanine aminotransferase (ALT) =< 1.5 x institutional ULN

Within 14 days of the first dose of study drug: Alanine aminotransferase (ALT) =< 3 x ULN

Alanine aminotransferase (ALT) level =< 2.5 × ULN.

Alanine aminotransferase (ALT) < 3 x ULN, unless due to the underlying leukemia approved by the PI

Alanine aminotransferase (ALT) ? 3 x ULN for age, unless elevation is due to leukemic infiltration

Alanine aminotransferase (ALT) ? 3.0 x ULN (unless considered due to leukemic organ involvement)

Alanine aminotransferase (ALT) > 45 U/L

Alanine aminotransferase (ALT) =< 3 x ULN.

Alanine aminotransferase (ALT) level =< 2.5 x ULN

Alanine aminotransferase (ALT) ? 1.5 x ULN

alanine aminotransferase (ALT) <= 3.0 x ULN*

Alanine aminotransferase (ALT) =< 2.5 x ULN

To be performed within 14 days prior to day 1 of protocol therapy: alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN.

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN within 14 days of study registration.

Alanine aminotransferase (ALT) (SPGT) is ? 3 X ULN for age

Alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN.

ALT (alanine aminotransferase) =< 2 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN

Obtained within 14 days of randomization: Alanine aminotransferase (ALT) =< 3 x ULN

alanine aminotransferase (ALT) ? 3.0 × ULN*

Alanine aminotransferase (ALT) =< 2.5 x ULN prior to biopsy

Alanine aminotransferase (ALT) =< 2.5 x ULN

LYMPHODEPLETION: Alanine aminotransferase (ALT) =< 3.0 x ULN, obtained within 72 hrs prior to procurement

Within 14 days prior to planned start of treatment: Alanine aminotransferase (ALT) =< 2 x ULN

Alanine aminotransferase (ALT) =< 1.5 x ULN for the laboratory

Alanine aminotransferase (ALT) < 3 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 3.0 x ULN

Alanine aminotransferase (ALT) < 1.5 x ULN

Alanine aminotransferase (ALT) =< 2 x ULN for the laboratory

Alanine transaminase (alanine aminotransferase [ALT]) > 3.0 x ULN

Alanine aminotransferase (ALT) =< 2.5 X ULN

Alanine aminotransferase (ALT) < 2.5 x ULN (3 x ULN for subjects on chronic anticonvulsive therapies known to increase transaminases).

Alanine aminotransferase (ALT) =< 3 x ULN for the laboratory, except in the presence of known hepatic metastasis, wherein the ALT may be =< 5 x ULN

Within 3 months of registration: Alanine aminotransferase (ALT) =< 2.5 x ULN

Within 14 days prior to study entry: Alanine aminotransferase (ALT) =< 3 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN for the laboratory

Alanine aminotransferase (ALT) =< 3.5 x ULN

AT THE TIME OF INFUSION: Alanine aminotransferase (ALT) ? 5 x normal

Alanine aminotransferase (ALT) =< 2.5 x ULN

Within 2 weeks of enrollment: Alanine aminotransferase (ALT) =< 3 x normal range

Alanine aminotransferase (ALT) =< 189 IU/L

Alanine aminotransferase (ALT) =< 3 x ULN unless considered due to leukemic involvement

Alanine aminotransferase (ALT) =< 2 x ULN

Alanine aminotransferase (ALT) > 3 x ULN

Alanine aminotransferase (ALT) ?110 units per Liter (U/L). For the purpose of this study, the ULN for ALT is 45 U/L

Alanine aminotransferase (ALT) > 2.5 X ULN or cirrhosis

Alanine aminotransferase (ALT) within the reference range during screening evaluation

Alanine aminotransferase (ALT) > 5 x ULN

To be performed within 14 days prior to day 1 of protocol therapy: alanine aminotransferase (ALT) =< 3 x ULN\r\n* If hepatic involvement by lymphoma: ALT =< 5 x ULN

Within 14 days prior to day 1 of protocol therapy unless otherwise stated: Alanine aminotransferase (ALT) =< 2 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN for the laboratory

Alanine aminotransferase (ALT) =< 3 x ULN

Alanine aminotransferase (ALT) < 1.5 X ULN; patients with Gilbert's disease are exempt from this criteria

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN for the laboratory

Alanine aminotransferase (ALT) =< 2.5 x ULN without, and =< 5 x ULN with hepatic metastasis

Alanine aminotransferase (ALT) ? 2 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN within 14 days prior to study registration

Alanine aminotransferase (ALT) =< 2.5 x ULN without, and =< 5 x ULN with hepatic metastasis

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase less than or equal to 3 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 1.5 X ULN

Alanine aminotransferase (ALT) > 2.5 x ULN

and alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

alanine aminotransferase (ALT) less than or equal to 2.5 × ULN*

Alanine aminotransferase (ALT) ? 1.5 x ULN unless there is hepatic involvement, then 3 x ULN

Alanine aminotransferase (ALT) ? 5 × institutional ULN

Within 30 days prior to initiation of protocol treatment: Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 3 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 1.5 x ULN

Alanine aminotransferase (ALT) < 5 x ULN age

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 1.5 x ULN

Alanine aminotransferase (ALT) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Alanine aminotransferase > 100 IU/L

Alanine aminotransferase (ALT) ?3 × ULN

Alanine aminotransferase (ALT) < 3 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN (=< 5.0 x ULN if considered due to leukemic involvement)

Alanine aminotransferase (ALT) < 300 IU/ml

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 1.5 X ULN

Alanine aminotransferase (ALT) =< 2.5 x the ULN (in the absence of hepatic involvement of tumor)

Alanine aminotransferase (ALT) ?3xULN

Alanine aminotransferase (ALT) =< 5 x ULN for age, unless the elevation is disease-related

Alanine aminotransferase (ALT) =< 3 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) > 3 x ULN for the laboratory

Serum alanine aminotransferase ? (ALT) 2.0 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase (ALT) =< 1.8 X ULN

Alanine aminotransferase (ALT) =< 1.5 x ULN

Alanine aminotransferase (ALT) =< 2.5 x ULN

Alanine aminotransferase =< 40 IU/dL